← Back to headlines
Sanofi's MenQuadfi Approved in EU for Infant Meningococcal Disease
Sanofi's MenQuadfi vaccine has received approval in the European Union for use in infants to protect against meningococcal disease.
4 Aug, 09:12 — 4 Aug, 09:12
Sources
Showing 1 of 1 sources
Related Stories
Piraeus Bank Completes Youth Financial Literacy Program
7m ago
AI Cloud Startup Volta Valued at $2.4 Billion, Announces $10 Billion Partnership
11m ago
Revolut Founder Nik Storonsky Sued for €17.5 Million Over Superyacht Commission
13m ago
Mészáros-Related Shares See Surge in Trading After Junk Rating Downgrade
17m ago